Practice-Changing Trials Expand Armamentarium and Improve Guidance in Advanced Breast Cancers

Several landmark trials have led to FDA approval milestones across all breast cancer subtypes in the past 5 years, each continuing to change the navigation of treatment approaches in clinical practice.

Related Keywords

Missouri ,United States ,Washington University ,Washington ,Cynthiax Ma ,Folusoo Bisi Ademuyiwa ,Katherine Clifton ,Nusaybaa Bagegni ,University School Of Medicine ,Cardinal Health ,Division Of Oncology ,Astrazeneca ,Pfizer ,Teladoc Health ,Washington University School Of Medicine ,Science Summit ,Breast Oncology ,Washington University School ,University School ,Washington University School Of Medicine In St Louis ,News ,Breast Cancer ,